CSRxP @RxPricing Twitter profile

Dose of Reality: Cancer Drug Prices

54

194

353

CSRxP

@RxPricing

3 years

The out-of-control prices set by #BigPharma on prescription drugs used to treat cancer have created a crisis of affordability – and placed breakthrough treatments out-of-reach for too many American patients. They must be held accountable for this price-gouging.

The man behind 'value-based pricing' saw pharma distorting his message — and walked away

24

133

353

CSRxP

@RxPricing

2 years

. @MickKolassa wrote #BigPharma ’s drug pricing playbook and is now exposing how the brand name drug industry went from bringing value to the market to taking advantage of it. Read the full story in @statnews :

Drug companies "weren't bringing anything of value to the market, they were taking advantage of the fundamental problems in the market, and I couldn't be part of that any more." — Mick Kolassa

www.statnews.com

5

98

312

CSRxP

@RxPricing

2 years

Despite little evidence of efficacy, #BigPharma set an egregious $56,000/yr list price on the drug Aduhelm. Now, 77% of voters agree clinical value and likely cost should be considered in @US_FDA approval decisions for new medications. More via @MorningConsult →

CSRxP Poll: See The Results

9

63

301

CSRxP

@RxPricing

2 years

#BigPharma uses shady tactics to repeatedly hike drug prices. We must enact solutions to cut down on these egregious practices.

Solutions - CSRxP

Americans deserve choice and control over their health. We must all work together to promote competition and increase access to high-quality, affordable treatments and cures for patients. It's time...

ANALYSIS FINDS BIG PHARMA REAPS BIG MULTIPLES FROM MEDICARE SPENDING

14

87

280

CSRxP

@RxPricing

2 years

A new @AARPpolicy analysis examining Medicare Part D from 2016-2020 on the 10 top-selling brand name drugs found that “on average, total Part D spending on the drugs reviewed over the 5-year period was more than 5 times higher than the average cost to develop a new drug.” More:

SECOND OPINION: BIG PHARMA’S PRICE HIKES HAVE LONG OUTPACED INFLATION

9

79

214

CSRxP

@RxPricing

2 years

Amid unprecedented momentum to hold #BigPharma accountable & lower #drugprices , @PhRMA is deflecting blame, falsely claiming “prescription drugs are not fueling inflation.” The facts are clear: Big Pharma’s price hikes have consistently outpaced inflation & caused rising costs.

CSRXP POLL: VOTERS SEE THROUGH BIG PHARMA’S BLAME GAME, WANT WASHINGTON TO LOWER DRUG PRICES & HOLD...

4

83

195

CSRxP

@RxPricing

2 years

ICYMI via a new @MorningConsult poll – voters overwhelmingly support market-based solutions to lower #drugprices & hold #BigPharma accountable →

Broad Majorities of Americans Blame Pharmaceutical Industry for Out-of-Control Drug Prices and Support Market-Based Solutions to Boost Affordability, Competition and Value Washington, D.C. – The...

BIG PHARMA WATCH: PHARMACEUTICAL COMPANIES HIKED LAUNCH PRICES BY 20 PERCENT EVERY YEAR FOR 14...

7

43

172

CSRxP

@RxPricing

2 years

According to new research published in @JAMA_current , “from 2008 to 2021, launch prices for new drugs increased by 20 percent per year.” Read more:

Nearly Half of All New Brand Name Drugs Cost More Than $150,000 Per Year In case you missed it, a new academic study published in The Journal of the American Medical Association (JAMA) from researc...

BIG PHARMA WATCH: PHARMACEUTICAL COMPANIES HIKED LAUNCH PRICES BY 2...

7

57

131

CSRxP

@RxPricing

2 years

A new study published in @JAMA_current showcases how #BigPharma increasingly engages in egregious pricing practices on brand name drugs. Researchers affiliated with @Harvard and @BrighamWomens found that companies hiked launch prices by 20% every year for 14 years →

BIG PHARMA EARNINGS WATCH: NOVARTIS, GLAXOSMITHKLINE, AMGEN, ROCHE - CSRxP

2

50

132

CSRxP

@RxPricing

2 years

Earnings from @Novartis , @GSK , @Amgen and @Roche bested #WallStreet expectations for Q1 – further demonstrating that price-gouging American patients continues to prove profitable for #BigPharma without action from Congress to hold them accountable:

Big Pharma Giants Repeatedly Hike Prices and Continue to Beat Wall Street Expectations This week, Novartis, GlaxoSmithKline, Amgen, and Roche all reported earnings for the first quarter. All four Big...

CSRxP Poll: See The Results

5

52

138

CSRxP

@RxPricing

2 years

From @MorningConsult : more than three in four voters support additional legislative and regulatory solutions to crack down on #BigPharma ’s egregious abuse of the patent system and boost competition in the prescription drug marketplace →

CSRxP Poll: See The Results

1

25

122

CSRxP

@RxPricing

2 years

As #drugprices continue to rise, voters know who’s to blame. It’s time for lawmakers to crack down on #BigPharma ’s out-of-control price gouging.

BIG PHARMA WATCH: REPORTS SHOW BIG PHARMA HAD ANOTHER BANNER YEAR IN 2021 - CSRxP

5

24

119

CSRxP

@RxPricing

2 years

ICYMI: @evaluatepharma and @endpts found that #BigPharma continued to reap massive profits and invest in shareholders while hiking prices on patients and pointing the blame for out-of-control #drugprices at others in the supply chain.

Brand Name Drug Companies Posted Massive Profit Growth and Invested Heavily in Share Buybacks and Dividends Two recent reports from Evaluate Vantage and Endpoints News detail the banner year Big...

Big Pharma's Blame Game Won't Lower Drug Prices for Americans - CSRxP

2

44

102

CSRxP

@RxPricing

2 years

While millions of Americans struggle to afford their medications, #BigPharma ’s price hikes continue to outpace inflation. It's time for Congress to act and hold Big Pharma accountable.

Hold #BigPharma Accountable

5

43

93

CSRxP

@RxPricing

5 years

Prescription #DrugPrices in America are out-of-control and the momentum for action is unprecedented. Congress must move quickly to hold #BigPharma accountable and lower prices.

The Rebate Rule Is A Big Pharma Bailout

3

30

83

CSRxP

@RxPricing

6 years

Some #drugprices news from @jessiehellmann : "Three U.S. senators are asking why a 40-year-old cancer drug has increased in price by 1,400 percent since 2013." @SenatorCollins , @clairecmc , and @SenCortezMasto send letter to Tri-Source Pharma

8

49

89

CSRxP

@RxPricing

7 years

Zoom in on the label of this prescription bottle

5

38

73

CSRxP

@RxPricing

4 years

The Admin's decision to advance the #RebateRule demonstrated shocking deference to the will of the #BigPharma . They should stand up to drug companies by withdrawing the Rebate Rule, leaving the critical 340B program alone & advancing solutions to hold Big Pharma accountable.

REBATE RULE A BIG PHARMA BAILOUT PAID FOR ON THE BACKS OF AMERICAN SENIORS AND TAXPAYERS - CSRxP

11

32

73

CSRxP

@RxPricing

4 years

The Rebate Rule is nothing short of a #BigPharma bailout paid for on the backs of American seniors and hardworking taxpayers. Learn more:

Administration Should Abandon Previously Rejected Measure That Rewards Drug Companies’ Pandemic Price Hikes and 340B Changes That Would Undermine Critical Program for Many of America’s Most Vulnera...

The Big Pharma Dollar: Investing Boldly in Advertising & Profits – NOT R&D. - CSRxP

6

33

71

CSRxP

@RxPricing

5 years

. @RxPricing took a hard look at the #BigPharmaDollar – and unfortunately for #BigPharma , when you break down their spending, the math just doesn’t match their rhetoric. These are the facts:

ICYMI: THE NEW YORK TIMES EDITORIAL BOARD ENDORSES SOLUTIONS TO CRACK DOWN ON BIG PHARMA’S PATENT...

7

40

64

CSRxP

@RxPricing

2 years

🚨The @nytimes editorial board is urging policymakers to advance patent reforms to stop #BigPharma from gaming the system.🚨

Highlights How Administration and Lawmakers Can Fix Loopholes Exploited by Pharmaceutical Companies to Keep Drug Prices High A new editorial from The New York Times Editorial Board highlights how Big...

“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part V - CSRxP

0

13

84

CSRxP

@RxPricing

5 years

. @Merck claims to “have a long history of responsibly pricing our medicines and vaccines.” The facts say otherwise. Time to give #BigPharma a #DoseofReality :

In advance of the U.S. Senate Committee on Finance hearing on February 26, 2019, the Campaign for Sustainable Rx Pricing (CSRxP) is releasing a blog series on what lawmakers can expect to hear from...

SECOND OPINION: BIG PHARMA’S PRICE HIKES HAVE LONG OUTPACED INFLATION

1

28

66

CSRxP

@RxPricing

2 years

#BigPharma ’s never-ending price hikes have outpaced inflation for years – escalating the affordability crisis for Americans who face financial uncertainty purchasing their medications and imposing heavy costs on taxpayers. Learn more:

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

3

36

65

CSRxP

@RxPricing

2 years

#BigPharma giant @JNJNews surpassed #WallStreet analysts’ earnings expectations in Q1 of 2022, growing sales and posting massive profits after hiking prices on several prescription drugs in their portfolio amid the winter pandemic surge. Read more:

SECOND OPINION: BIG PHARMA’S PRICE HIKES HAVE LONG OUTPACED INFLATION

4

14

61

CSRxP

@RxPricing

5 years

🔥 Prepare for the grilling… It’s time to get answers from #BigPharma

2

18

40

CSRxP

@RxPricing

2 years

DYK: #BigPharma traditionally hikes prescription #drugprices in two major batches each year — the first starting in January and the second starting in July. Learn how their egregious practices have caused #RxPrices to rise at rates faster than #inflation ↓

Fact Sheet: Innovation 2022

4

32

46

CSRxP

@RxPricing

2 years

#BigPharma ’s innovation rhetoric is bogus – and policymakers must see through the pharmaceutical industry’s smoke and mirrors excuses to enact market-based solutions that hold brand name drug makers accountable and lower prescription #DrugPrices . →

Big Pharma’s Blame Game Won’t Lower Drug Prices for Americans - CSRxP

1

11

42

CSRxP

@RxPricing

2 years

Have you seen #BigPharma ’s ads blaming others for out-of-control prescription #drugprices ? They claim to be investing in R&D – but are actually investing millions in advertising instead to keep drug prices out-of-control and evade accountability for price-gouging Americans.

STUDY: 1/3 OF SENIORS DON’T FILL PRESCRIPTIONS FOR HIGH-PRICE DRUGS

1

14

39

CSRxP

@RxPricing

2 years

#BigPharma ’s sky-high launch prices & price hikes for life-saving drugs are NOT connected to increases in clinical value. Americans need Congress to crack down on #BigPharma ’s pricing practices that are the underlying cause of out-of-control #RxPrices . More:

Dose of Reality: The Real Stories Behind Big Pharma's Price Gouging - CSRxP

3

10

42

CSRxP

@RxPricing

5 years

#BigPharma ’s actions don’t take place in a vacuum. Meet the real patients paying the price for #BigPharma ’s price gouging tactics. @SenateAging @DemsOnAging

Northeast: [Maryland] Parkinson Patient Larry Zarzecki: “I Can’t Afford The Best Drugs On The Market, Even With My Insurance, And I Have Good Insurance.” “[Larry] Zarzecki, a retired state...

Business Daily - Dying for insulin in the USA - BBC Sounds

2

14

30

CSRxP

@RxPricing

5 years

Via @nytimes : “ @SenFinance must not allow drug makers to point the finger elsewhere on Tuesday.”

1

14

30

CSRxP

@RxPricing

4 years

American diabetics are forced to pay some of the highest prices for insulin in the world. It's costing many their lives, and the rest of the world is taking notice. Listen via @BBC →

Why do American diabetics have to pay so much for this life-saving drug?

www.bbc.co.uk

0

23

34

CSRxP

@RxPricing

5 years

. @Abbvie CEO says “we make decisions based on our deep caring and compassion for people,” but is okay with 100% price hikes? Something isn’t adding up. #BigPharma needs a #DoseofReality :

DOSE OF REALITY: BIG PHARMA’S TRACK RECORD IS A HARD PILL TO SWALLOW

CSRXP APPLAUDS MOMENTUM TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES - CSRxP

2

11

25

CSRxP

@RxPricing

2 years

We applaud the momentum to address out-of-control prescription #drugprices and hold #BigPharma accountable. This is a real opportunity for market-based solutions to deliver more choices, more competition, and lower prices. Read our full statement:

Congress Should Swiftly Advance Solutions to Deliver Relief for Millions of Americans Hurt By Brand Name Drug Companies’ Egregious Practices Washington, D.C. – The Campaign for Sustainable Rx Pricing...

The Hidden Hand: Big Pharma's Influence on Patient Advocacy Groups

1

15

30

CSRxP

@RxPricing

3 years

To undermine drug pricing solutions, #BigPharma funds patient groups and maintains an arsenal of astroturf third-party organizations and so-called charities. Learn more from this eye-opening report by @P4AD_ :

patientsforaffordabledrugs.org

0

13

21

CSRxP

@RxPricing

5 years

. @pfizer claims to believe that “the best means to address affordability of medicines is to reduce the growing out-of-pocket costs.” Well, they’re not doing so hot. Get a #DoseofReality :

“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part VI - CSRxP

In advance of the U.S. Senate Committee on Finance hearing on February 26, 2019, the Campaign for Sustainable Rx Pricing (CSRxP) is releasing a blog series on what lawmakers can expect to hear from...

The Hidden Hand: Big Pharma's Influence on Patient Advocacy Groups

5

11

19

CSRxP

@RxPricing

5 years

Today’s #DoseofReality looks at the rhetoric of @AstraZeneca CEO Pascal Soriot compared to his company’s track record of price hikes:

0

8

22

CSRxP

@RxPricing

3 years

A new report by @P4AD_ finds that many patient advocacy groups are funded by #BigPharma – creating conflicts of interest in the pursuit of drug price affordability. Read here:

patientsforaffordabledrugs.org

1

8

21

CSRxP

@RxPricing

2 years

#BigPharma ’s egregious price hikes and pricing practices are putting life-saving medications out of reach for millions of Americans – and must be stopped.

Big Pharma's Blame Game Won't Lower Drug Prices for Americans - CSRxP

Column: Gilead says drug profits must stay high to pay for 'innovation,' but 100% of its profits...

1

4

22

CSRxP

@RxPricing

6 years

So where do those profits go? In ‘16, Gilead had $13.5b profit - spent $11b on share buybacks and $2.5b on dividend. Nothing wrong with profit, but let’s not pretend that high #drugprices are being plowed back into R&D

With high drug prices still in the political crosshairs on Capitol Hill, pharmaceutical industry bosses are at pains to explain why a cure for hepatitis-C has to cost a budget-busting $1,000 per...

www.latimes.com

1

2

4

CSRxP

@RxPricing

2 years

The millions of Americans facing financial uncertainty affording their medications have waited too long for action in Washington & are counting on Congress to finally deliver on repeated promises to lower #drugprices by cracking down on #BigPharma ’s egregious price-gouging. More:

CSRXP APPLAUDS MOMENTUM TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWE...

1

4

16

CSRxP

@RxPricing

5 years

Of the 100 best-selling #BigPharma drugs, nearly 80% have extended their patents to block generic competition at least once, and 50% have extended them multiple times. Stop the patent abuse.

Pharma lobbying for Medicare "fix" in opioids bill

0

6

15

CSRxP

@RxPricing

6 years

Must-read new report from @IMAKglobal today demonstrates the lengths that #BigPharma will go to thwart competition from #generics & #biosimilars and keep #drugprices artifically high, costing the #healthcare system billions each year

1

16

CSRxP

@RxPricing

8 years

. @RepJohnDuncanJr : "I'm a very conservative pro-business Republican but I'm really sickened by what I've heard here..." #EpiPen #DrugPrices

0

9

11

CSRxP

@RxPricing

5 years

Without competition, #BigPharma can run wild, with American seniors paying the price. We need a real fix like the CREATES Act to make drugs more affordable. @SenateAging @DemsOnAging

0

5

18

CSRxP

@RxPricing

6 years

#BigPharma ’s #donuthole fix is really a $4 billion bailout, making seniors who rely on Medicare Part D pay more. More via @caitlinnowens @bobjherman →

Democrats may not go along.

www.axios.com

0

7

15

CSRxP

@RxPricing

6 years

. @ChuckGrassley & @SenatorDurbin offering amendments to #minibus that would give @US_FDA authority to require #drugprices in DTC ads & appropriate $1m to fund implementation by @US_FDA

Durbin Presses Senate To Support Bipartisan Amendments Requiring Drug Companies To Disclose Prices...

The Official U.S. Senate website of Dick Durbin

www.durbin.senate.gov

1

4

13

CSRxP

@RxPricing

5 years

It’s simple: when #BigPharma is allowed to run wild, they line their pockets at the expense of patients. @WaysMeansCmte

“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part IV - CSRxP

2

9

15

CSRxP

@RxPricing

5 years

FACTS: Of the 100 best selling drugs, the makers of nearly 80 percent have extended their patents at least once to block generic competition and maintain monopolies on these critical medications. @senjudiciary

1

9

13

CSRxP

@RxPricing

5 years

. @jnjnews will tell you “we believe our first responsibility is to the patients.” Here’s a #DoseofReality :

In advance of the U.S. Senate Committee on Finance hearing on February 26, 2019, the Campaign for Sustainable Rx Pricing (CSRxP) is releasing a blog series on what lawmakers can expect to hear from...

THEY SAID IT! LAWMAKERS SLAM MODERNA FOR EGREGIOUS COVID-19 VACCINE...

1

8

10

CSRxP

@RxPricing

3 years

We applaud @POTUS for calling for bipartisan action to lower #drugprices . This is a top priority for American voters who need relief from #BigPharma ’s egregious pricing and anti-competitive practices. We look forward to working with the admin and Congress to get this done.

1

3

14

CSRxP

@RxPricing

5 years

. @SenatorBaldwin is standing up for patients against #BigPharma 's abuse. Her #FAIRDrugPricing Act will help do what all Americans need: hold #BigPharma accountable.

1

7

13

CSRxP

@RxPricing

7 years

Over 2 decades, price of milk is up 23%, Dodge Caravan up 21%, insulin up 1157% #drugprices

0

16

12

CSRxP

@RxPricing

1 year

The heat was on during a recent Senate HELP Committee hearing 🔥. @moderna_tx couldn't justify raising the price of their COVID-19 vaccine by nearly 500%. It's clear that they and other #BigPharma companies only care about maximizing profits. More here →

0

2

14

CSRxP

@RxPricing

7 years

#Insulin was discovered nearly 100 years ago, yet the price of the drug has now spiked by 700% in just two decades.

1

14

10

CSRxP

@RxPricing

5 years

#BigPharma has become a master manipulator, using shady tactics to keep #DrugPrices high. It’s time for the truth to come out. @WaysMeansCmte

Big Pharma must be held accountable for insulin price crisis

0

7

9

CSRxP

@RxPricing

6 years

“247 patent applications have been filed on Humira in the U.S. with the aim of delaying competition for 39 years.” @IMAKglobal ’s case study examines how overpatenting by #BigPharma hinders competition and drives up #drugprices →

1

13

12

CSRxP

@RxPricing

5 years

#BigPharma ’s strategy: find a drug patients can’t live without, then hike hike hike! Pharma sees the 7.4 million insulin-dependent diabetics not as patients, but as profits. Via @Runaway_Rx

0

8

9

CSRxP

@RxPricing

5 years

“With advancements in research and development, the price of insulin should be going down. Instead, pharmaceutical companies keep raising the price simply to pad their bottom lines.” Sarah Gleich, Diabetic @SenFinance @SenFinance

I have had diabetes since I was 5 years old. Like millions of people with diabetes, I rely on insulin 24 hours a day to survive.

lasvegassun.com

0

8

11

CSRxP

@RxPricing

5 years

🥇Congratulations to #BigPharma for setting yet another record… this time for spending a record-high $275 million on lobbying to keep #DrugPrices high.

0

9

CSRxP

@RxPricing

6 years

#BigPharma ’s unrelenting efforts to get their bailout is just another attempt to hijack something meant to help people and turn it into an opportunity to price-gouge patients. We won’t stand for it. #NoBigPharmaBailout

1

3

9

CSRxP

@RxPricing

5 years

“Humira is protected by over 130 patents…these patens block generic competition that could bring down the price for biologics.” - @SenatorCollins , @SenateAging Read more about #BigPharma ’s anticompetitive tactics:

The Truth About Big Pharma’s Patent Abuse - CSRxP

Big Pharma is able to price gouge patients and avoid accountability. For decades, drug makers have gamed the patent system to block out competition and protect their profits – maintaining monopolies...

Stop Big Pharma’s $4 Billion Bailout - CSRxP

0

7

8

CSRxP

@RxPricing

6 years

❌ MYTH: #BigPharma -backed donut hole changes will “fix” #Medicare Part D: ✅ FACT: #BigPharma ’s solution is a bailout in their favor – and will dramatically raise prices for patients, especially seniors:

As the country is hoping for lower drug prices, more affordable care, and solutions to the opioid epidemic sweeping the nation, Big Pharma is making backroom deals with Congress to fund a $4 billion...

How Big Pharma Reaps Profits While Hurting Everyday Americans

0

4

8

CSRxP

@RxPricing

7 years

@PhRMA Let’s talk about markups - eg how the markup paid by US Px far outstrips global #BigPharma R&D spend #drugprices

0

2

7

CSRxP

@RxPricing

5 years

No one should miss meals to pay for their medications. These are the stories behind #BigPharma ’s price hikes: @SenateAging @DemsOnAging

0

5

10

CSRxP

@RxPricing

5 years

. @pfizer raised the price of Lyrica 2,316 times between 2015 - 2019. @pfizer also spent $272 million on Lyrica advertisements in 2018 alone. Don’t buy #BigPharma ’s rhetoric, their massive price hikes are used to pay for ad buys and to bank higher profits.

1

4

11

CSRxP

@RxPricing

6 years

In @thehill , @DeanClancy pens a must-read op-ed on the "no-brainer" #CREATESAct - "Between these two extremes lies an elegant, bipartisan, and broadly popular solution: the Creates Act, which would reduce drug prices without harming anyone." #Drugprices

2

8

11

CSRxP

@RxPricing

4 years

#BigPharma hiked prices on more than 3,400 drugs this year resulting in millions of dollars in new revenue, while Americans struggle every day to afford their medications.

The pharmaceutical industry leverages Washington’s culture of corruption to increase profits while everyday Americans suffer from high drug prices.

www.americanprogress.org

0

2

9

CSRxP

@RxPricing

5 years

ICYMI: #BigPharma as a whole runs rampant with patent abuse to keep #drugprices high – but these take the cake! @SenJudiciary , no more of this! Via @IMAKglobal →

0

4

11

CSRxP

@RxPricing

6 years

Op-ed on #CREATESAct from @freedomworks ' @pye & @dansav1776 : "One would think that, with this bipartisan agreement, a common sense solution could be enacted. Such a solution does exist, and it comes in the form of the CREATES Act." #drugprices #bigpharma

1

5

7

CSRxP

@RxPricing

1 year

Cracking down on #BigPharma ’s anti-competitive tactics will help lower #drugprices for patients. Don’t buy the bogus Big Pharma blame game designed to evade accountability and keep prices high. Learn more:

The Solution - CSRxP

Merck raised prices five drugs including Keytruda in November

8

2

7

CSRxP

@RxPricing

7 years

It's time for #BigPharma to get their priorities straight: American's deserve open and honest prescription drug pricing.

1

9

8

CSRxP

@RxPricing

6 years

Honest question -- is there another industry that "limits" the annual price increase of their (old and unchanged) products to 9.9% and expects applause for it? #drugprices #bigpharma

3

6

8

CSRxP

@RxPricing

5 years

More proof #BigPharma will never do the right thing. After pledging to delay price hikes, @Merck is following @pfizer ’s back to “business as normal,” increasing prices on important drugs – from cancer treatments to vaccines that prevent infections like HPV

Merck & Co Inc said on Wednesday it raised U.S. prices on five of its drugs earlier in November by between 1.5 percent and 6 percent, including its top-selling cancer treatment Keytruda.

www.reuters.com

1

10

9

CSRxP

@RxPricing

5 years

We commend @SenatorBraun for his unwavering support for the #FAIRDrugPricingAct . This legislation is a vital step to hold #BigPharma accountable!

1

2

9

CSRxP

@RxPricing

7 years

#PriceGougi $ol: #BigPharma ’s latest outrageously expensive drug

1

4

9

CSRxP

@RxPricing

2 years

“People are struggling to afford their prescription drugs. It’s ridiculous. It’s immoral… if the only kinds of innovations you’re generating are ones that patients can’t afford, that’s not real innovation in the rest of the economy.” More from @FREOPP president, @Avik Roy:

SECOND OPINION: AVIK ROY DEBUNKS BIG PHARMA’S INNOVATION RHETORIC

0

5

9

CSRxP

@RxPricing

5 years

#BigPharma games the patent system to block competition and protect their profits. By maintaining monopolies they drive up prices without improving the medications patients need most. Get the facts.

CSRXP: OVERSIGHT REPORT ADDS TO MOMENTUM IN WASHINGTON TO HOLD BIG PHARMA ACCOUNTABLE - CSRxP

0

7

CSRxP

@RxPricing

6 years

Out-of-control #drugprices drove a banner week for #BigPharma earnings

0

5

9

CSRxP

@RxPricing

5 years

ICYMI: #CREATESAct and other key #DrugPricing bills have received a bipartisan 👍 👍 from @EnergyCommerce , signaling bipartisan momentum to continue to advance and pass into law.

0

2

9

CSRxP

@RxPricing

3 years

We applaud Chairwoman @RepMaloney and members of House leadership for their continued commitment to holding #BigPharma accountable and delivering lower drug prices for the American people. Read our statement on the committee’s new report:

U.S. House Oversight & Reform Committee Report Shines Light on Branded Drugmakers’ Profiteering Practices, Debunks Innovation Rhetoric Washington, D.C. – The Campaign for Sustainable Rx Pricing...

Big Pharma's Blame Game Won't Lower Drug Prices for Americans - CSRxP

2

7

8

CSRxP

@RxPricing

6 years

Decades old drug went from free to $109,000/year. Really gets you in the holiday spirit. Or something. #drugprices

2

8

6

CSRxP

@RxPricing

2 years

#BigPharma ’s bogus blame game is designed to keep #drugprices high and pad their bottom line. It’s time for leaders in Washington to hold them accountable for their anti-competitive practices and price-gouging.